This the success of the Edmonton Protocol for treating diabetes using allogeneic islets, the need for sources of islet cells has intensified. The patent addresses that need through teaching ways of growing and expanding islet cells from pancreatic stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.